Language: BG BG
← Back to results
Approved for marketing NCT04437004

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Conditions: Dravet Syndrome

Sponsor: University of California, Los Angeles

trial.available_in: БГ
Overview
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Description
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Who can participate
Inclusion Criteria: * Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures.
Interventions
Fenfluramine
DRUG
Locations 1
United States (1)
University of California, Los Angeles
Los Angeles , California
Technical details
Status
Approved for marketing
Study type
EXPANDED_ACCESS
Sex
Male and female
Minimum age
2 Years
Healthy volunteers
No
Registry ID
NCT04437004
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.